NCPA to CMS: Follow health reform law with new AMP formula
The Centers for Medicare and Medicaid Services (CMS) should closely follow congressional guidance included in the health care reform law as the agency implements a new formula for Medicaid generic drug reimbursement based on average manufacturer price (AMP), according to the National Community Pharm